Cite
HARVARD Citation
Imaoka, H. et al. (2019). Alternate Endpoints for Phase II Trials in Advanced Neuroendocrine Tumors. Oncologist. pp. 47-53. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Imaoka, H. et al. (2019). Alternate Endpoints for Phase II Trials in Advanced Neuroendocrine Tumors. Oncologist. pp. 47-53. [Online].